Cipla Limited (CIPLA) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Cipla Limited (CIPLA) has a cash flow conversion efficiency ratio of 0.041x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs13.45 Billion ≈ $145.49 Million USD) by net assets (Rs330.25 Billion ≈ $3.57 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CIPLA market cap overview for the company's overall valuation and market capitalisation.
Cipla Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Cipla Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Cipla Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cipla Limited ranked by their cash flow conversion efficiency. Explore cash flow quality index of Cipla Limited to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Revvity Inc.
NYSE:RVTY
|
0.016x |
|
Sonova H Ag
SW:SOON
|
0.169x |
|
CARLSBERG B DK20 ADR 1/5
F:CBGC
|
N/A |
|
Sociedad Quimica y Minera de Chile SA ADR B
NYSE:SQM
|
0.078x |
|
NIPPON YUSEN K.K.SP.DR1/5
F:NYK
|
N/A |
|
Hong Leong Bank Bhd
KLSE:5819
|
0.055x |
|
Exelixis Inc
NASDAQ:EXEL
|
0.154x |
|
Henan Shuanghui Investment & Development Co Ltd
SHE:000895
|
0.061x |
Annual Cash Flow Conversion Efficiency for Cipla Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Cipla Limited from 2004 to 2025. View Cipla Limited share price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs312.89 Billion ≈ $3.38 Billion |
Rs50.05 Billion ≈ $541.27 Million |
0.160x | +3.71% |
| 2024-03-31 | Rs268.03 Billion ≈ $2.90 Billion |
Rs41.34 Billion ≈ $447.07 Million |
0.154x | +12.97% |
| 2023-03-31 | Rs237.14 Billion ≈ $2.56 Billion |
Rs32.38 Billion ≈ $350.14 Million |
0.137x | -13.31% |
| 2022-03-31 | Rs211.17 Billion ≈ $2.28 Billion |
Rs33.26 Billion ≈ $359.68 Million |
0.157x | -22.05% |
| 2021-03-31 | Rs185.86 Billion ≈ $2.01 Billion |
Rs37.55 Billion ≈ $406.11 Million |
0.202x | +5.73% |
| 2020-03-31 | Rs160.57 Billion ≈ $1.74 Billion |
Rs30.68 Billion ≈ $331.84 Million |
0.191x | +73.39% |
| 2019-03-31 | Rs153.44 Billion ≈ $1.66 Billion |
Rs16.91 Billion ≈ $182.89 Million |
0.110x | +9.87% |
| 2018-03-31 | Rs145.82 Billion ≈ $1.58 Billion |
Rs14.63 Billion ≈ $158.19 Million |
0.100x | -45.32% |
| 2017-03-31 | Rs129.82 Billion ≈ $1.40 Billion |
Rs23.82 Billion ≈ $257.58 Million |
0.183x | +25.06% |
| 2016-03-31 | Rs118.66 Billion ≈ $1.28 Billion |
Rs17.41 Billion ≈ $188.26 Million |
0.147x | +37.30% |
| 2015-03-31 | Rs109.82 Billion ≈ $1.19 Billion |
Rs11.73 Billion ≈ $126.90 Million |
0.107x | -40.73% |
| 2014-03-31 | Rs86.68 Billion ≈ $937.38 Million |
Rs15.63 Billion ≈ $169.00 Million |
0.180x | +16.34% |
| 2013-03-31 | Rs90.19 Billion ≈ $975.34 Million |
Rs13.98 Billion ≈ $151.15 Million |
0.155x | -30.88% |
| 2012-03-31 | Rs76.38 Billion ≈ $826.07 Million |
Rs17.13 Billion ≈ $185.23 Million |
0.224x | +45.08% |
| 2011-03-31 | Rs66.33 Billion ≈ $717.29 Million |
Rs10.25 Billion ≈ $110.86 Million |
0.155x | -12.42% |
| 2010-03-31 | Rs59.11 Billion ≈ $639.21 Million |
Rs10.43 Billion ≈ $112.80 Million |
0.176x | +104.69% |
| 2009-03-31 | Rs43.48 Billion ≈ $470.20 Million |
Rs3.75 Billion ≈ $40.54 Million |
0.086x | -11.79% |
| 2008-03-31 | Rs37.55 Billion ≈ $406.11 Million |
Rs3.67 Billion ≈ $39.69 Million |
0.098x | -5.42% |
| 2007-03-31 | Rs32.36 Billion ≈ $349.99 Million |
Rs3.34 Billion ≈ $36.17 Million |
0.103x | -26.06% |
| 2006-03-31 | Rs19.83 Billion ≈ $214.48 Million |
Rs2.77 Billion ≈ $29.97 Million |
0.140x | +8.56% |
| 2005-03-31 | Rs15.54 Billion ≈ $168.02 Million |
Rs2.00 Billion ≈ $21.63 Million |
0.129x | -35.24% |
| 2004-03-31 | Rs12.64 Billion ≈ $136.70 Million |
Rs2.51 Billion ≈ $27.17 Million |
0.199x | -- |
About Cipla Limited
Cipla Limited, together with its subsidiaries, manufactures, develops, sells, and distributes pharmaceutical products in India, the United States, South Africa, and internationally. The company operates through Pharmaceuticals and New Ventures segments. It offers generic and branded generic medicines, vaccines, active pharmaceutical ingredients, and formulations for various therapeutic areas, suc… Read more